Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 3Phase NA 1Phase 3 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Dermatologic 1

Conditions

Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Leukemia, Myeloid, Acute 1Congenital Abnormalities 1Chromosome 5q Deletion Syndrome 1

Interventions

Cyclophosphamide 21fludarabine phosphate 15Cyclosporine 13Antilymphocyte Serum 13Peripheral Blood Stem Cell Transplantation 12Busulfan 12Whole-Body Irradiation 11Mycophenolic Acid 10Filgrastim 8fludarabine 7Methotrexate 7Melphalan 7Therapeutics 5Radiotherapy 5Cytarabine 5Blood Specimen Collection 5Tacrolimus 4Psychiatric Rehabilitation 4Methylprednisolone 4Cord Blood Stem Cell Transplantation 4thymoglobulin 3Stem Cell Transplantation 3Palliative Care 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Flow Cytometry 3Dexamethasone 3Behavior Therapy 3Aprepitant 3sargramostim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Cytogenetic Analysis × Myeloid × Clear all
NCT00445744 2018-01-02

Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

Fred Hutchinson Cancer Center

Phase NA Completed
52 enrolled 7 charts
MyeloidOther hematologic neoplasm

Chromosome 5q Deletion Syndrome, Congenital Abnormalities, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡